Infection and lung transplantation;Infecciones en el trasplante pulmonar

Archivos de Bronconeumologia

Volumn 32, Issue 9, 1996, Pages 442-446

  Carreno M C ^a,b   Ussetti, P ^a   Varela, A ^a   Mendaza, P ^a   Daza, R ^a   Ferreiro, M J ^a   Jaurena, J ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Servico de Mcdicina Interna   (Spain)

Author keywords

Cytomegalovirus; Infections; Lung transplantation; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; ANTIFUNGAL AGENT; ANTIVIRUS AGENT;

ANTIBODY BLOOD LEVEL; ARTICLE; ASPERGILLOSIS; BACTERIUM CULTURE; BRONCHOSCOPY; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; DONOR; EARLY DIAGNOSIS; FUNGUS CULTURE; HUMAN; INFECTION; LUNG BIOPSY; LUNG LAVAGE; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; PNEUMOCYSTIS PNEUMONIA; PREOPERATIVE EVALUATION; PROPHYLAXIS; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE; SURVIVAL; TUBERCULOSIS;

EID: 0029797149     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30703-1     Document Type: Article

References (26)

1. Jenkinson SG, Levine SM. Lung transplantation. Diseasc-a-month 1994; 40: 1-40.
2. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990; 11: 291-308.
3. Rubin RH, Tolkoff-Rubin NE. The impact of infection on the outcome of transplantation. Trans Proc 1991; 23: 2.068-2.074.
4. Sweny P. Infections in organ transplantation. Current Opinion Infections Dis 1991; 4: 375-794.
5. a ed.). Nueva York: Plenum, 1994; 629.
6. Dowling RD, Zenati M, Yousem SA et al. Donor transmitted pneumonia in experimental lung allografts: successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg 1992; 103: 767-772.
7. Zenati M, Dowling RD, Dummer JS et al. Influence of the donor lung on development of early infections in lung trasplant recipients. J Heart Transplant 1990; 9: 502-509.
8. Zenati M, Dowling RD, Armitage JM et al. Organ procurement for pulmonary transplantation. Ann Thorac Surg 1989; 48: 882-886.
9. Deussch E, End A, Grimm M et al. Early bacterial infections in lung trasplant recipients. Chest 1993; 104: 1.412-1.416.
10. Low ED, Kaiser LR, Haydock A et al. The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. J Thorac Cardiovasc Surg 1993; 106: 614-621.
11. Ciulli F, Tamm M, Dennis C et al. Donor-transmitted bacterial infection in heart-lung transplantation. Trans Proc 1993; 25: 1.155-1.156.
12. Horvath J, Dummer S, Loyd J et al. Infection in the trasplanted and native lung after single lung transplantation. Chest 1993; 104: 681-685.
13. Kramer MR, Denning DW, Marshall SE et al. Ulcerative tracheobronchitis after lung transplantation. Am Rev Respir Dis 1991; 144: 552-556.
14. Denning DD, Tucker RM, Hanson LH et al. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989; 86: 791-800.
15. Burke C, Glanville A, Macoviack M et al. The spectrum of cytomegalovirus infections following heart-lung transplantation. J Heart Transplant 1986; 5: 267-272.
16. Duncan AJ, Dummer JS, Paradis IL et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 1991; 10: 638-646.
17. Maurer JR, Tullis DE, Scavuzzo M et al. Cytomegalovirus infection in isolated lung transplantations. J Heart Lung Transplant 1991; 10: 647-649.
18. Burke C, Theodore J, Dawkings K et al. Post-transplant obliterative bronchiolitis and other late long sequelae in human heart-lung transplantation. Chest 1984; 86: 824-829.
19. Bailey TC, Trulock EP, Ettinger NA et al. Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J Infect Dis 1992; 165: 548-552.
20. Snydman DR. Prevention of cytomegalovirus-associated diseases with immunoglobulin. Transplant Proc 1991; 23: 131-135.
21. Balfour HH, Chace BA, Stapleton JT et al. A randomized placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 1989; 320: 1.381-1.387.
22. Kennan RJ, Lega ME, Drumer JS et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433-438.
23. Paradis IL, GrGurich WF, Dekker A et al. Rapid detection of cytomegalovirus pneumonia by evaluation of bronchoalveolar cells. Am Rev Respir Dis 1988; 138: 697.
24. Randhawa PS, Yousem SA, Paradis IL et al. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 1989; 92: 177-185.
25. Preiksaitis JH, Díaz-Mitoma F, Mirzayans F et al. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosupresive therapy, scrologic responses and the risk of postransplant lymphoproliferative disorder. J Infect Dis 1992; 166: 986-994.
26. Pirsch JD, Stratta RJ, Sollinger HW et al. Treatment of severe Epstein-Barr vims-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. Am J Med 1989; 86: 241-244.